Gastrointestinal Cancer News

Lion TCR received approval from the Health Sciences Authority in Singapore to perform a phase 1/2 multicenter clinical study of its LioCyx candidate for treating liver cancer relapse after liver transplant, according to a press release.

Screening patients with cirrhosis for hepatocellular carcinoma using either or both abdominal ultrasonography and serum alpha fetoprotein did not correlate with decreased HCC-related mortality, according to a study recently published in Gastroenterology.

The FDA approved lenvatinib capsules for the first-line treatment of patients with unresectable hepatocellular carcinoma.

From 1999 to 2016, all-cause mortality among adults aged between 25 years and 64 years in many different ethnic groups in the United States increased while life expectancy in the United States plateaued from 2010 to 2016, according to two studies published in BMJ.

Diminutive polyps in the distal colon that do not have to be removed can be reliably identified by real-time, computer-aided diagnosis for colonoscopy, according to data published in Annals of Internal Medicine.

A modified combination of docetaxel, cisplatin and fluorouracil conferred a long-lasting response and appeared well tolerated among patients with advanced anal squamous cell carcinoma, according to findings from a single-arm, multicenter, phase 2 study.

Patients with gastric cancer and MUC16-mutant tumors had longer median OS than patients with wild-type MUC16, according to study results published in JAMA Oncology.

The FDA granted the PapGene liquid biopsy test breakthrough device designation for the detection of cancer among people aged older than 65 years, according to the manufacturer.

Few individuals reported being aware of the association between insufficient physical activity and increased risk for cancer, according to findings from a cross-sectional survey.

Noninvasive focused ultrasound hyperthermia enhanced intratumoural delivery of doxorubicin among patients with liver tumors, according to study results published in The Lancet Oncology.